Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 2
1961 2
1964 1
1965 1
1973 2
1978 1
1980 1
1981 1
1982 1
1985 1
1986 2
1988 1
1989 1
1990 1
1991 9
1992 13
1993 12
1994 30
1995 19
1996 24
1997 35
1998 34
1999 34
2000 33
2001 42
2002 43
2003 42
2004 45
2005 46
2006 57
2007 60
2008 73
2009 69
2010 84
2011 73
2012 69
2013 63
2014 64
2015 65
2016 53
2017 54
2018 52
2019 45
2020 64
2021 83
2022 61
2023 53
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,501 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, Grymowicz M, Smolarczyk K, Kostrzak A, Smolarczyk R, Rudnicka E, Meczekalski B. Szeliga A, et al. Int J Mol Sci. 2021 Mar 5;22(5):2594. doi: 10.3390/ijms22052594. Int J Mol Sci. 2021. PMID: 33807517 Free PMC article. Review.
Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As the ovaries are a common target for autoimmune attacks, an autoimmune etiology of POI should always be considered, especially in the p …
Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As the ovar …
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L. Bjørklund G, et al. Autoimmun Rev. 2022 Aug;21(8):103135. doi: 10.1016/j.autrev.2022.103135. Epub 2022 Jun 9. Autoimmun Rev. 2022. PMID: 35690244 Review.
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-endocrine manifestations in childhood. ...The prevalence rate is highest in genetically isolated populations (up to 1:6500-1:9000). APS-1 oc
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-
Autoimmune polyglandular diseases.
Kahaly GJ, Frommer L. Kahaly GJ, et al. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101344. doi: 10.1016/j.beem.2019.101344. Epub 2019 Oct 4. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31606344 Review.
Autoimmune polyglandular diseases (APD) are defined as the presence of two autoimmune -induced endocrine failures. ...Considering the high incidence of one or more endocrinopathies in first-degree relatives of patients with APD, family members should be regul
Autoimmune polyglandular diseases (APD) are defined as the presence of two autoimmune -induced endocrine failures. ...C
Polyglandular autoimmune syndromes.
Kahaly GJ, Frommer L. Kahaly GJ, et al. J Endocrinol Invest. 2018 Jan;41(1):91-98. doi: 10.1007/s40618-017-0740-9. Epub 2017 Aug 17. J Endocrinol Invest. 2018. PMID: 28819917 Review.
METHODS: Review of the pertinent and current literature. RESULTS: Polyglandular autoimmune syndromes (PAS) are multifactorial diseases with at least two coexisting autoimmune-mediated endocrinopathies. PAS show a great heterogeneity of syndromes and manifest …
METHODS: Review of the pertinent and current literature. RESULTS: Polyglandular autoimmune syndromes (PAS) are multifactorial dise
Autoimmune Polyendocrine Syndromes.
Husebye ES, Anderson MS, Kämpe O. Husebye ES, et al. N Engl J Med. 2018 Mar 22;378(12):1132-1141. doi: 10.1056/NEJMra1713301. N Engl J Med. 2018. PMID: 29562162 Free PMC article. Review. No abstract available.
Autoinmune polyendocrinopathy.
Fernández Miró M, Colom Comí C, Godoy Lorenzo R. Fernández Miró M, et al. Med Clin (Barc). 2021 Sep 10;157(5):241-246. doi: 10.1016/j.medcli.2021.02.004. Epub 2021 May 3. Med Clin (Barc). 2021. PMID: 33958142 Review. English, Spanish.
Pluriglandular autoimmune syndrome (APS) can affect multiple endocrine glands and is associated with other autoimmune diseases. ...SPA type 3 is characterized by autoimmune thyroid disease and other autoimmune disease, excluding Addison's diseas …
Pluriglandular autoimmune syndrome (APS) can affect multiple endocrine glands and is associated with other autoimmune disea
A Review of Autoimmune Enteropathy and Its Associated Syndromes.
Chen CB, Tahboub F, Plesec T, Kay M, Radhakrishnan K. Chen CB, et al. Dig Dis Sci. 2020 Nov;65(11):3079-3090. doi: 10.1007/s10620-020-06540-8. Epub 2020 Aug 24. Dig Dis Sci. 2020. PMID: 32833153 Review.
Autoimmune enteropathy is an extremely rare condition characterized by an abnormal intestinal immune response which typically manifests within the first 6 months of life as severe, intractable diarrhea that does not respond to dietary modification. ...The diagnosis is made
Autoimmune enteropathy is an extremely rare condition characterized by an abnormal intestinal immune response which typically manifes
Autoimmune enteropathies.
Umetsu SE, Brown I, Langner C, Lauwers GY. Umetsu SE, et al. Virchows Arch. 2018 Jan;472(1):55-66. doi: 10.1007/s00428-017-2243-7. Epub 2017 Oct 11. Virchows Arch. 2018. PMID: 29022145 Review.
Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea and immune-mediated injury of the intestinal mucosa. As the clinical and histopathologic manifestations of this disease are highly variable, its diagnosis is challenging for both clinici
Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea and immune-mediated injury of the intestinal m
Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type II and III.
Pham-Dobor G, Hanák L, Hegyi P, Márta K, Párniczky A, Gergics M, Sarlós P, Erőss B, Mezősi E. Pham-Dobor G, et al. J Endocrinol Invest. 2020 Sep;43(9):1-9. doi: 10.1007/s40618-020-01229-1. Epub 2020 Aug 17. J Endocrinol Invest. 2020. PMID: 32227311 Free PMC article.
PURPOSE: Polyglandular autoimmune syndromes (PAS) are complex, heterogeneous disorders in which various autoimmune diseases can occur, affecting both endocrine and non-endocrine organs. ...In addition, one other endocrine and five non-endocrine organ-specific …
PURPOSE: Polyglandular autoimmune syndromes (PAS) are complex, heterogeneous disorders in which various autoimmune diseases
Autoimmune Polyendocrinopathy.
Frommer L, Kahaly GJ. Frommer L, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4769-4782. doi: 10.1210/jc.2019-00602. J Clin Endocrinol Metab. 2019. PMID: 31127843
CONTEXT: This mini-review offers an update on the rare autoimmune polyendocrinopathy (AP) syndrome with a synopsis of recent developments. ...Addison disease is the major endocrine component of type II (ORPHA 3143), whereas the coexistence of type 1 diabetes and autoimm
CONTEXT: This mini-review offers an update on the rare autoimmune polyendocrinopathy (AP) syndrome with a synopsis of recent developm …
1,501 results